Previous Close | 1.7700 |
Open | 1.7600 |
Bid | 1.7400 x 800 |
Ask | 1.7500 x 1100 |
Day's Range | 1.7200 - 1.7600 |
52 Week Range | 1.3700 - 8.3800 |
Volume | |
Avg. Volume | 789,419 |
Market Cap | 100.973M |
Beta (5Y Monthly) | 1.60 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2330 |
Earnings Date | Nov 02, 2022 - Nov 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 11.10 |
Subscribe to Yahoo Finance Plus to view Fair Value for SURF
The analysts covering Surface Oncology, Inc. ( NASDAQ:SURF ) delivered a dose of negativity to shareholders today, by...
If you want to know who really controls Surface Oncology, Inc. ( NASDAQ:SURF ), then you'll have to look at the makeup...
– SRF388 clinical data presented at 2022 ASCO Annual Meeting demonstrated monotherapy responses in two different indications, combination activity and notable disease stabilization – – Interim SRF617 clinical data anticipated in the fourth quarter of 2022 – – Multiple clinical readouts anticipated in 1H 2023, including initial safety and efficacy data from SRF388 open-label, lead-in to randomized Phase 2 study in first-line hepatocellular carcinoma (HCC) – – Cash sufficient to fund operations in